Christopher Reilly-Stitt reports on two UK NEQAS BC webinars held in April and July, and the response received from an international online audience.
UK NEQAS Blood Coagulation (BC) has continued to provide external quality assessment (EQA) during these challenging times. However, the NEQAS team has not been able to offer the now well-recognised and attended annual scientific conference in 2020 or 2021. The conference, when convening normally, offers clinical and laboratory staff two days of presentations from renowned international speakers covering a range of the most currently topical areas in the specialty. With this in mind, in order to attempt to fill this void, UK NEQAS BC has organised a series of webinar sessions, two of which have already taken place one in April and one in July 2021. These webinars have been provided free of charge to delegates and are open to all.
The webinars were planned to deliver some of the already arranged programme from the cancelled 2020 meeting, and address the emerging vaccine-induced immune thrombocytopenia and thrombosis (VITT) issue that started to become apparent in spring 2021. The first webinar held in April this year was in the field of haemophilia therapies, with three sessions to cover the clinical, scientific and proficiency testing aspects of this rapidly developing area of medicine. Three expert speakers in the field presented their talks before being available for a question-and-answer (Q&A) session.
Haemophilia therapies in April
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
